New 'triple pill' could eliminate high blood pressure

A new combination drug may have the potential to revolutionize hypertension treatment worldwide, after a clinical trial has declared it safe to use and very effective.

13 April 2021 | Health

In a recent clinical trial led by researchers from the George Institute for Global Health — with branches in the United Kingdom, Australia, and India — they tested the effectiveness and safety of using an innovative drug for the treatment of high blood pressure, or hypertension.

This drug, nicknamed the “triple pill” by the investigators, combines low doses of three existing drugs for blood pressure.

Namely, these are: telmisartan (20 milligrams), amlodipine (2.5 milligrams), and chlorthalidone (12.5 milligrams).

According to World Health Organization (WHO) data from 2008, about 40 perecentTrusted Source of adults aged over 25 had raised blood pressure worldwide. The WHO also estimate that hypertension is responsible for 7.5 million of all deaths across the globe.

That is because this condition is a major risk factor for both heart disease and stroke, making it a priority to have effective treatments in place for the regulation of blood pressure.

Normally, people with hypertension start taking one blood pressure drug at low doses, only to have to return to their doctors time and again. They then get prescriptions for increasingly higher doses and more hypertension drugs.

According to study co-author Dr. Ruth Webster, “Patients are brought back [to the doctor’s office] at frequent intervals to see if they are meeting their targets with multiple visits required to tailor their treatments and dosage.”

“The problem with this approach,” she adds, is that it “is not only time inefficient, it’s costly. We also know that many doctors and patients find it too complicated and often don’t stick to the process.”

So, Dr. Webster and colleagues tested a method that, they hoped, would be more efficient, would not have additional side effects, and would remove some of the inconveniences related to a traditional treatment.

This is how they came up with the “triple pill,” which combines fixed low doses of three already existent drugs commonly used to treat hypertension.

‘Triple pill’ vs. traditional therapy

The clinical trial testing the efficacy and safety of the new combination pill took place in Sri Lanka. It involved 700 participants — aged 56, on average — whose average blood pressure amounted to 154/90 millimeters of mercury (mm Hg), which is a typical sign of hypertension.

Of all the participants, some took the combination pill, while others continued to follow their usual blood pressure-lowering therapy, as per their doctors’ advice.

In contrast to those following traditional therapy for hypertension, a larger number of those taking the combination pill were able to lower their blood pressure effectively, reaching their target pressure of 140/90 mm Hg or under.

The target for individuals with diabetes or kidney disease was 130/80 mm Hg, which many people taking the “triple pill” were able to reach.

More specifically, 70 percent of the people taking the “triple pill” achieved their target blood pressure, compared with a little over 50 percent of the participants who continued on traditional hypertension therapy.

In the study paperTrusted Source they published in JAMA, the authors explain that after 6 months from the start of the trial, 83 percent of the people who had started on the “triple pill” were still following this same treatment.

To the contrary, most of the participants following a traditional treatment had added medication or increased drug quantities by the 6-month mark.

“The World Heart Federation [have] set an ambitious goal that by 2025 there will be a 25 percent reduction in blood pressure levels globally,” says study co-author Prof. Anushka Patel.

“The triple pill,” she continues, “could be a low-cost way of helping countries around the world to meet this target.”

Researchers at the George Institute believe that their “triple pill” could really make a difference to current therapy for hypertension.

Right now, the team is looking into the combination drug’s cost effectiveness for various countries and putting into place strategies to make the drug accessible across the world. “This study has global relevance,” says Prof. Patel. – Source: Medicalnewstoday

Similar News

 

Shangula pours cold water over Covishield fears

15 hours ago | Health

JEMIMA BEUKES WINDHOEKHealth minister Dr Kalumbi Shangula has allayed fears that the Covishield...

Did you know?

2 days ago - 03 May 2021 | Health

Death among children and adolescentsAccidents (unintentional injuries) are, by far, the leading cause of death among children and teens.Health tipRegular hand washing helps prevent the...

Children: improving survival and well-being

2 days ago - 03 May 2021 | Health

Children aged 1 to 11 months accounted for 1.5 million of these deaths while children aged 1 to 4 years accounted for 1.3 million deaths....

Connected children

2 days ago - 03 May 2021 | Health

*Half of ten-year-olds now own their own smartphone.*Use of smart speakers among children aged 5-15 has doubled.*More children watch video-on-demand (VoD) than watch live broadcast...

Costly infertility treatment bankrupts families – Geingos

6 days ago - 29 April 2021 | Health

NAMPA WINDHOEKThe lack of infertility treatment at public hospitals makes it costly for many families and often bankrupts...

Covid-19 vaccination roll-out accelerates

6 days ago - 29 April 2021 | Health

JEMIMA BEUKES WINDHOEKSince the roll-out of the Covid-19 vaccination plan, Cabinet members have lined...

Health ministry earmarks N$3 billion for salaries

1 week ago - 27 April 2021 | Health

NAMPAWINDHOEKThe ministry of health and social services will spend N$3 267 468 000 on salaries during the 2021/2022 financial year.This is according to minister of...

Migraine linked to increased risk of high blood pressure...

1 week ago - 27 April 2021 | Health

Migraine is a debilitating disorder, often resulting in multiple severe headaches a month, and typically experienced more often by women than men. This according to...

Ambulance drivers party like it’s 2019

1 week ago - 26 April 2021 | Health

JEMIMA BEUKESWINDHOEKA team of ministry of health ambulance drivers, responsible for transporting confirmed and suspected Covid-19 cases, allegedly held a birthday party at a state-sanctioned...

Covid-19 vaccination starts in Otjozondjupa

1 week ago - 26 April 2021 | Health

ESTER KAMATIOTJIWARONGOA ceremony was held at the Otjiwarongo state hospital on Wednesday where the first doses of Covid-19 vaccine were administered, with the regional governor...

Latest News

Local cosmetics industry growing

15 hours ago | Business

Namibia’s cosmetics industry has grown considerably and 34 businesses currently export products worth over N$100 million per year. The minister of Industrialisation and trade, Lucia...

More than N$10 bn in...

15 hours ago | Economics

Jo-Maré Duddy – Commercials banks last year granted clients severely impacted by the Covid-19 pandemic debt relief to the tune of N$10.3 billion in total.About...

Shiimi kicks out Agribank board...

15 hours ago | Agriculture

MATHIAS HAUFIKU WINDHOEKAgribank board chairperson Michael Iyambo was recently forced to resign from his...

Kora trial: We were misled,...

15 hours ago | Justice

ELLANIE SMIT WINDHOEK The Namibia Tourism Board (NTB) was misled and wrongly made to believe that the organisers of the failed...

Africa Briefs

15 hours ago | Economics

Zambia, Angola ink oil pipeline dealZambia and Angola have signed an agreement aimed at constructing a pipeline for the transportation of finished petroleum product between...

Quit singing songs of fake...

15 hours ago | Opinion

Whose freedom is the blood of those who perished in Cassinga watering? This is one in a myriad of questions we must ask ourselves as...

Bumper six months for Agra

15 hours ago | Business

Jo-Maré Duddy – Agra Limited weathered the Covid-19 storm in the six months ended 31 January 2021, reporting an increase of nearly 66% year-on-year in...

Police can’t find army general’s...

15 hours ago | Justice

Kenya Kambowe RUNDUThe second suspect in a stock-theft case involving former Namibia Defence Force (NDF) Major-General Thomas Hamuyela is nowhere to...

Shangula pours cold water over...

15 hours ago | Health

JEMIMA BEUKES WINDHOEKHealth minister Dr Kalumbi Shangula has allayed fears that the Covishield...

Load More